Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 Photo Shaari Rai Poken
Kweku
From Bloemfontein to Bremen: Kweku Gavor represented South Africa well in Germany.

It all started with the Umoja Buddy Programme (UBP). Kweku Gavor was a UBP ambassador when he met exchange students from Germany. Two years later, the roles were reversed. “Helping out students who later have become my really good friends opened up the opportunity for me to study abroad in Germany.” he said.

Kweku spent about four months as part of a pilot Summer Lab Programme at Universität Bremen after being nominated for a scholarship by the German Academic Exchange Service, which his former Umoja buddies helped create. He shared the experience with eight other students from Palestine, Poland, Ukraine, and the US. The focus was on Business Studies, Marketing and Economics.

According to the BCom graduate, studying internationally gave him new insights. “The experience opened my mind and better-equipped me to work in situations in which I need to handle a lot of pressure against the clock.”

The first leg of the programme featured corresponding modules presented in a classroom environment, which were integrated with assignments, presentations, tests and exams. This was supplemented by a language course that involved cultural leadership training. Another crucial part of the Summer Lab Programme was an internship where students were placed with companies and tasked with a problem-solving project. Kweku was placed at Fabular Ai, an artificial intelligence company which designs computer software.

“Going to study abroad is an extremely rare and fantastic opportunity I advise all who can to grab it with both hands,” said Kweku, who also used the opportunity to travel all over Europe.

Internationalisation at home with Umoja

The UBP, which is collaboratively run by the UFS Office for International Affairs and Student Affairs, played a big part in Kweku being given the opportunity to study abroad. However, unlike him, not all students have to the opportunity to engage in undergraduate exchanges.

The UBP is part of the university’s efforts to advance internationalisation at home, as anchored in the UFS Strategic Plan: 2018-2022. With the programme, students are able to receive an international experience on home ground.

The programme aims to connect international and local students through meaningful lifelong friendships and foster their academic, social and cultural integration. It pairs first-entry international students with senior Kovsies who provide a warm, welcoming, friendly face, and a helping hand.

Expression of interest sought

A total of 48 ambassadors were enrolled in 2019. To join the UBP in 2020, contact Sonya Kapfumvuti at KapfumvutiSCR@ufs.ac.za or call her on 051 401 3397.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept